Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Dennis Dietrich
1494
mi
from 43215
Great Falls, MT
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Dennis Dietrich
1494
mi
from 43215
Great Falls, MT
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
University of Medicine and Dentistry of New Jersey School of Neurology
424
mi
from 43215
Stratford, NJ
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
University of Medicine and Dentistry of New Jersey School of Neurology
424
mi
from 43215
Stratford, NJ
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Upstate Clinical Research LLC 3
515
mi
from 43215
Albany, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Upstate Clinical Research LLC 3
515
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Neurological Specialists of Long Island
492
mi
from 43215
Great Neck, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Neurological Specialists of Long Island
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Multiple Sclerosis Center of Northeastern NY
479
mi
from 43215
New York, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Multiple Sclerosis Center of Northeastern NY
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Comprehensive MS Care Clinic at South Shore Multiple Sclerosis
529
mi
from 43215
Patchogue, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Comprehensive MS Care Clinic at South Shore Multiple Sclerosis
529
mi
from 43215
Patchogue, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Carolinas Medical Center
349
mi
from 43215
Charlotte, NC
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Carolinas Medical Center
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Meritcare Neuroscience Center Neurology
837
mi
from 43215
Fargo, ND
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Meritcare Neuroscience Center Neurology
837
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
MS Center of Oklahoma
848
mi
from 43215
Oklahoma City, OK
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
MS Center of Oklahoma
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Neurology and Sleep Medicine
404
mi
from 43215
Bethlehem, PA
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Neurology and Sleep Medicine
404
mi
from 43215
Bethlehem, PA
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Swedish Medical Center - Cherry Hill
2006
mi
from 43215
Seattle, WA
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Swedish Medical Center - Cherry Hill
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Neurology & Neurological Association of Tacoma
2013
mi
from 43215
Tacoma, WA
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Neurology & Neurological Association of Tacoma
2013
mi
from 43215
Tacoma, WA
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Instituto Medico Rodriguez Alfici
5116
mi
from 43215
Godoy Cruz,
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Instituto Medico Rodriguez Alfici
5116
mi
from 43215
Godoy Cruz,
Click here to add this to my saved trials
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated:  9/22/2017
University of Chicago
270
mi
from 43215
Chicago, IL
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated: 9/22/2017
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated:  10/3/2017
Stony Brook Univeristy
524
mi
from 43215
Stony Brook, NY
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated: 10/3/2017
Stony Brook Univeristy
524
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Electric Stimulation of the Eye to Improve Vision After Trauma
Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma
Status: Enrolling
Updated:  11/1/2017
Wills Eye Hospital
416
mi
from 43215
Philadelphia, PA
Electric Stimulation of the Eye to Improve Vision After Trauma
Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma
Status: Enrolling
Updated: 11/1/2017
Wills Eye Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Status: Enrolling
Updated:  11/2/2017
University of Colorado
1173
mi
from 43215
Boulder, CO
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Status: Enrolling
Updated: 11/2/2017
University of Colorado
1173
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated:  11/9/2017
University of Texas at Austin
1064
mi
from 43215
Austin, TX
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated: 11/9/2017
University of Texas at Austin
1064
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
2111
mi
from 43215
San Francisco, CA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
2111
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
1980
mi
from 43215
Torrance, CA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigator Site
459
mi
from 43215
Iowa City, IA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigator Site
459
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis
345
mi
from 43215
Baltimore, MD
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
416
mi
from 43215
Philadelphia, PA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
9459
mi
from 43215
Camperdown,
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
9459
mi
from 43215
Camperdown,
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington Medicine MS Center
2007
mi
from 43215
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington Medicine MS Center
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington; Harborview Medical Center
2006
mi
from 43215
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington; Harborview Medical Center
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington, Health Sciences Building
2007
mi
from 43215
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington, Health Sciences Building
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
Single Center, Randomized, Open Label Study in Relapsing MS Patients on PLEGRIDY to Assess Topical Application of Preparation H (Phenylephrine) on Mitigation of Erythema Severity and Size.
Status: Enrolling
Updated:  12/18/2017
New York University School of Medicine
479
mi
from 43215
New York, NY
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
Single Center, Randomized, Open Label Study in Relapsing MS Patients on PLEGRIDY to Assess Topical Application of Preparation H (Phenylephrine) on Mitigation of Erythema Severity and Size.
Status: Enrolling
Updated: 12/18/2017
New York University School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
MS Symptom Management Study
Enhancing the Benefits of Pain and Fatigue Treatment in MS
Status: Enrolling
Updated:  12/21/2017
University of Washington, Ninth and Jefferson Building
2007
mi
from 43215
Seattle, WA
MS Symptom Management Study
Enhancing the Benefits of Pain and Fatigue Treatment in MS
Status: Enrolling
Updated: 12/21/2017
University of Washington, Ninth and Jefferson Building
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Effects of Vaporized Marijuana on Neuropathic Pain
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated:  1/11/2018
CTSC Clinical Research Center, Sacramento VA Medical Center
2042
mi
from 43215
Sacramento, CA
Effects of Vaporized Marijuana on Neuropathic Pain
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated: 1/11/2018
CTSC Clinical Research Center, Sacramento VA Medical Center
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Barrow Neurological Institute
1661
mi
from 43215
Phoenix, AZ
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Barrow Neurological Institute
1661
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Stanford University
2100
mi
from 43215
Stanford, CA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Stanford University
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
1154
mi
from 43215
Aurora, CO
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Shepherd Center
432
mi
from 43215
Atlanta, GA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Shepherd Center
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Johns Hopkins
345
mi
from 43215
Baltimore, MD
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Johns Hopkins
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Beth Israel Deaconess
643
mi
from 43215
Boston, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Beth Israel Deaconess
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Univ of Massachusetts Med School
604
mi
from 43215
Worcester, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Univ of Massachusetts Med School
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Multiple Sclerosis Research Center of New York
478
mi
from 43215
New York, NY
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Multiple Sclerosis Research Center of New York
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Ohio State University
2
mi
from 43215
Columbus, OH
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
UT Southwestern Medical Center
911
mi
from 43215
Dallas, TX
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
UT Southwestern Medical Center
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
Status: Enrolling
Updated:  1/13/2018
Department of Health and Exercise Science
1161
mi
from 43215
Fort Collins, CO
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
Status: Enrolling
Updated: 1/13/2018
Department of Health and Exercise Science
1161
mi
from 43215
Fort Collins, CO
Click here to add this to my saved trials
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
Status: Enrolling
Updated:  1/25/2018
EMD Serono, Inc.
647
mi
from 43215
Rockland, MA
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
Status: Enrolling
Updated: 1/25/2018
EMD Serono, Inc.
647
mi
from 43215
Rockland, MA
Click here to add this to my saved trials
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2018
MS Center at Evergreen Health
2001
mi
from 43215
Kirkland, WA
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2018
MS Center at Evergreen Health
2001
mi
from 43215
Kirkland, WA
Click here to add this to my saved trials
Methylphenidate to Improve Balance and Walking in MS
Methylphenidate to Improve Balance and Walking in MS
Status: Enrolling
Updated:  3/8/2018
Portland VA Medical Center
2027
mi
from 43215
Portland, OR
Methylphenidate to Improve Balance and Walking in MS
Methylphenidate to Improve Balance and Walking in MS
Status: Enrolling
Updated: 3/8/2018
Portland VA Medical Center
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated:  3/8/2018
LSU Health Sciences Center - Shreveport
783
mi
from 43215
Shreveport, LA
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated: 3/8/2018
LSU Health Sciences Center - Shreveport
783
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
Pilot Study of Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications (OUCH)
Status: Enrolling
Updated:  3/14/2018
MS Center at Evergreen Health
2001
mi
from 43215
Kirkland, WA
Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
Pilot Study of Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications (OUCH)
Status: Enrolling
Updated: 3/14/2018
MS Center at Evergreen Health
2001
mi
from 43215
Kirkland, WA
Click here to add this to my saved trials
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  3/15/2018
Tisch MS Research Center of New York
478
mi
from 43215
New York, NY
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 3/15/2018
Tisch MS Research Center of New York
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Phoenix Neurological Associates
1656
mi
from 43215
Phoenix, AZ
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Phoenix Neurological Associates
1656
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Multiple Sclerosis Center of Northeastern New York
516
mi
from 43215
Latham, NY
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Multiple Sclerosis Center of Northeastern New York
516
mi
from 43215
Latham, NY
Click here to add this to my saved trials